title: Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications.
abstract: Glycerophospholipids containing arachidonic acid (20:4) serve as the precursors for an array of biologically active lipid mediators, most of which are produced by macrophages. We have applied mass spectrometry-based lipid profiling technology to evaluate the glycerophospholipid structure and composition of two macrophage populations, resident peritoneal macrophages and RAW264.7 cells, with regard to their potential for 20:4-based lipid mediator biosynthesis. Fatty acid analysis indicated that RAW264.7 cells were deficient in 20:4 (10 +/- 1 mol %) compared to peritoneal macrophages (26 +/- 1 mol %). Mass spectrometry of total glycerophospholipids demonstrated a marked difference in the distribution of lipid species, including reduced levels of 20:4-containing lipids, in RAW264.7 cells compared to peritoneal macrophages. Enrichment of RAW264.7 cells with 20:4 increased the fatty acid to 20 +/- 1 mol %. However, the distribution of the incorporated 20:4 remained different from that of peritoneal macrophages. RAW264.7 cells pretreated with granulocyte-macrophage colony stimulating factor followed by lipopolysaccharide and interferon-gamma mobilized similar quantities of 20:4 and produced similar amounts of prostaglandins as peritoneal macrophages treated with LPS alone. LPS treatment resulted in detectable changes in specific 20:4-containing glycerophospholipids in peritoneal cells, but not in RAW264.7 cells. 20:4-enriched RAW264.7 cells lost 88% of the incorporated fatty acid during the LPS incubation without additional prostaglandin synthesis. These results illustrate that large differences in glycerophospholipid composition may exist, even in closely related cell populations, and demonstrate the importance of interpreting the potential for lipid-mediator biosynthesis in the context of overall glycerophospholipid composition.
authors.affiliation: Department of Biochemistry, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
authors.forename: Carol A
authors.initials: CA
authors.lastname: Rouzer
authors.forename: Pavlina T
authors.initials: PT
authors.lastname: Ivanova
authors.forename: Mark O
authors.initials: MO
authors.lastname: Byrne
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Milne
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Marnett
authors.forename: H Alex
authors.initials: HA
authors.lastname: Brown
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000172:deficiency*; D002460:Cell Line; D005227:Fatty Acids / Q000032:analysis / Q000378:metabolism*; D020404:Glycerophospholipids / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects / Q000502:physiology*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000502:physiology; D051379:Mice; D008813:Mice, Inbred ICR; D010743:Phospholipids / Q000378:metabolism*
chemical_list: D005227:Fatty Acids; D020404:Glycerophospholipids; D008070:Lipopolysaccharides; D010743:Phospholipids; D016718:Arachidonic Acid